MOORE CAPITAL MANAGEMENT, LP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$6,507,000
+465.8%
30,000
+200.0%
0.08%
+78.3%
Q3 2019$1,150,000
-33.3%
10,0000.0%0.05%
+12.2%
Q2 2019$1,724,000
+2.3%
10,0000.0%0.04%
-21.2%
Q1 2019$1,686,000
+15.4%
10,000
-33.3%
0.05%
-10.3%
Q4 2018$1,461,000
-57.7%
15,000
-25.0%
0.06%
-21.6%
Q3 2018$3,455,000
+23.8%
20,0000.0%0.07%
+8.8%
Q2 2018$2,791,000
+147.6%
20,000
+100.0%
0.07%
+195.7%
Q1 2018$1,127,000
-57.3%
10,000
-50.0%
0.02%
-52.1%
Q4 2017$2,640,000
+160.1%
20,000
+100.0%
0.05%
+140.0%
Q3 2017$1,015,000
+1.2%
10,0000.0%0.02%
-35.5%
Q2 2017$1,003,000
-17.0%
10,0000.0%0.03%
-6.1%
Q1 2017$1,209,000
+8.1%
10,0000.0%0.03%
-8.3%
Q4 2016$1,118,000
-60.2%
10,000
-75.3%
0.04%
-58.6%
Q4 2015$2,812,000
+23.4%
40,500
+62.0%
0.09%
+74.0%
Q1 2015$2,278,000
+108.8%
25,000
+85.2%
0.05%
+100.0%
Q3 2014$1,091,000
-77.4%
13,500
-70.0%
0.02%
-78.4%
Q2 2014$4,828,000
+137.8%
45,000
+31.6%
0.12%
+182.9%
Q1 2014$2,030,00034,2000.04%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders